GENETIC TECHNOLOGIES LIMITED
0.039AUDD
+0.001+2.63%
At close at Nov 30, 2024, 17:46 GMT
AUD
No trades
GTG fundamentals
GENETIC TECHNOLOGIES LIMITED revenue breakdown overview
GENETIC TECHNOLOGIES LIMITED revenue for the last year amounted to 7.66 M AUD, the most of which — 6.16 M AUD — came from its highest performing source at the moment, EasyDNA, the year earlier bringing 7.70 M AUD. The greatest contribution to the revenue figure was made by Europe, Middle East and Africa — last year it brought GENETIC TECHNOLOGIES LIMITED 4.07 M AUD, and the year before that — 4.49 M AUD.
By source
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
2.50 M
5.00 M
7.50 M
10.00 M
EasyDNA
AffinityDNA
GeneType/Corporate
Genetic Testing and Risk Assessment Tools
Research
Licensing
Corporate
Biotech
Investment
Currency: AUD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
EasyDNA
—
—
6.00 M
7.70 M
6.16 M
AffinityDNA
—
—
—
944.06 K
1.37 M
GeneType/Corporate
—
—
793.39 K
43.45 K
134.09 K
Genetic Testing and Risk Assessment Tools
9.86 K
120.55 K
—
—
—
Research
—
—
—
—
—
Licensing
—
—
—
—
—
Corporate
—
—
—
—
—
Biotech
—
—
—
—
—
Investment
—
—
—
—
—
By country
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
2.50 M
5.00 M
7.50 M
10.00 M
Europe, Middle East and Africa
Asia Pacific
America and Canada
Latin America
Australia
United States
China
Canada
Switzerland
Currency: AUD
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Europe, Middle East and Africa
—
—
2.50 M
4.49 M
4.07 M
Asia Pacific
—
—
1.89 M
1.63 M
1.74 M
America and Canada
—
—
2.27 M
2.24 M
1.67 M
Latin America
—
—
128.84 K
322.03 K
190.42 K
Australia
3.16 K
102.42 K
—
—
—
United States
6.70 K
18.14 K
—
—
—
China
—
—
—
—
—
Canada
—
—
—
—
—
Switzerland
—
—
—
—
—